McKeage, M. J., Gu, Y., Wilson, W. R., Hill, A., Amies, K., Melink, T. J., & Jameson, M. B. (2011). A phase I trial of PR-104, a pre-prodrug of the bioreductive prodrug PR-104A, given weekly to solid tumour patients. BioMed Central.

McKeage, Mark J., Yongchuan Gu, William R. Wilson, Andrew Hill, Karen Amies, Teresa J. Melink, και Michael B. Jameson. A Phase I Trial of PR-104, a Pre-prodrug of the Bioreductive Prodrug PR-104A, Given Weekly to Solid Tumour Patients. BioMed Central, 2011.

McKeage, Mark J., et al. A Phase I Trial of PR-104, a Pre-prodrug of the Bioreductive Prodrug PR-104A, Given Weekly to Solid Tumour Patients. BioMed Central, 2011.